Zum Hauptinhalt springen
| Hans-Günter Meyer-Thompson | International

FDA Shutting Down Fentanyl Access Program for Cancer Patients

FDA Shutting Down Fentanyl Access Program for Cancer Patients

The U.S. Food and Drug Administration is shutting down a pain management program that helped supply fentanyl medication to patients suffering from severe cancer pain. 

In a notice published on the FDA’s website for its Transmucosal Immediate-Release Fentanyl Medicines (TIRF) program, the agency said that all TIRF medications “will be discontinued” on September 30. (Pain News Network, USA, 12.09.2024)

https://www.painnewsnetwork.org/stories/tag/FDA